“Deep morphea as an Unusual Cause of Body Asymmetry”
Deep morphea as an unusual cause of body asymmetry
DOI:
https://doi.org/10.59722/rmcu.v3i1.1130Keywords:
deep morphea, lineal scleroderma, skin fibrosis, tissue atrophyAbstract
Deep morphea is a rare variant of localized scleroderma characterized by cutaneous induration and involvement of deeper soft tissues, whose progression may ultimately result in functional impairment. We report the case of a 43-year-old woman with a 21-year history of disease, marked by progressive atrophy, rigidity, and restriction of range of motion, in the absence of systemic manifestations. Physical examination revealed notable body asymmetry and residual cutaneous changes affecting the right hemiabdomen and the left lower extremity. Histopathological analysis demonstrated fibrosis of the dermis and subcutaneous tissue, reduced cellularity, and collagen thickening, findings consistent with a chronic inactive stage. Additional laboratory studies showed normal inflammatory markers and negative autoantibody testing. Given the patient’s limited tolerance to immunosuppressive therapy, a conservative management approach with physical therapy was pursued. This case underscores the slowly progressive yet primarily localized nature of deep morphea and highlights the importance of a multidisciplinary strategy to optimize long-term functional outcomes.
Downloads
References
Kreuter A, Moinzadeh P, Kinberger M, Horneff G, Worm M, Werner RN, et al. S2k guideline: Diagnosis and therapy of localized scleroderma. J Dtsch Dermatol Ges [Internet]. 2024;22(4):605–20. Disponible en: http://dx.doi.org/10.1111/ddg.15328
Mateos-Mayo A, Sánchez-Herrero A, Vilas Boas-da Silva PT, Ruedas-Martínez A, Suárez-Fernández R, Avilés-Izquierdo JA. Características clínicas y epidemiológicas de los pacientes con esclerodermia. Piel (Barc, Internet) [Internet]. 2020;35(2):72–6. Disponible en: http://dx.doi.org/10.1016/j.piel.2019.04.002
Keum H, Chen HW, Haley RW, Jacobe HT. Incidence and prevalence of morphea. JAMA Dermatol [Internet]. 2024;160(10):1128–30. Disponible en: http://dx.doi.org/10.1001/jamadermatol.2024.2993
Ayala Servin N, Duré Martinez MA, Urizar González CA, González M, Contreras CR. Esclerodermia cutánea localizada (Morfea): Reporte de caso. Med Clín Soc [Internet]. 2021;5(2):100–5. Disponible en: http://dx.doi.org/10.52379/mcs.v5i2.168
Iancau A, Attia S, Duarte Silva F, Eajazi A, Malja E, Xi Y, et al. Localized scleroderma: anatomic MRI findings of morphea with inter-reader analysis. Skeletal Radiol [Internet]. 2025;54(10):2055–65. Disponible en: http://dx.doi.org/10.1007/s00256-025-04909-2
Hernandez A, Zapata Leiva L, Mutka M, Torok KS, Ledbetter L, Zigler CK. Endpoints and outcomes for localized scleroderma/morphea: a scoping literature review. Pediatr Rheumatol Online J [Internet]. 2024;22(1):77. Disponible en: http://dx.doi.org/10.1186/s12969-024-01014-x
Papara C, De Luca DA, Bieber K, Vorobyev A, Ludwig RJ. Morphea: The 2023 update. Front Med (Lausanne) [Internet]. 2023;10:1108623. Disponible en: http://dx.doi.org/10.3389/fmed.2023.1108623
Sozeri B, Turkmen S, Atikan BY, Aktug H. Histopathological and molecular analysis in dermis and epidermis of patients with systemic and localized scleroderma. North Clin Istanb [Internet]. 2025;12(2):189–95. Disponible en: http://dx.doi.org/10.14744/nci.2024.45389
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista Médico Científica UNACHI

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Esta obra está bajo una Licencia Creative Commons Atribución-NoComercial 4.0 Internacional.











